• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Zoledronate-Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma.

作者信息

Lundberg A P, Roady P J, Somrak A J, Howes M E, Fan T M

机构信息

Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Urbana, IL.

Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Urbana, IL.

出版信息

J Vet Intern Med. 2016 Jul;30(4):1235-40. doi: 10.1111/jvim.13980. Epub 2016 Jun 14.

DOI:10.1111/jvim.13980
PMID:27296235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5089613/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f4/5153974/5f4e92ca1b85/JVIM-30-1235-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f4/5153974/43e03a2e11a7/JVIM-30-1235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f4/5153974/9a28b428258b/JVIM-30-1235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f4/5153974/18f875962786/JVIM-30-1235-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f4/5153974/5f4e92ca1b85/JVIM-30-1235-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f4/5153974/43e03a2e11a7/JVIM-30-1235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f4/5153974/9a28b428258b/JVIM-30-1235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f4/5153974/18f875962786/JVIM-30-1235-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f4/5153974/5f4e92ca1b85/JVIM-30-1235-g004.jpg

相似文献

1
Zoledronate-Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma.唑来膦酸相关颌骨坏死在一只患有附肢骨肉瘤的犬中的情况
J Vet Intern Med. 2016 Jul;30(4):1235-40. doi: 10.1111/jvim.13980. Epub 2016 Jun 14.
2
Zoledronic acid for the treatment of appendicular osteosarcoma in a dog.唑来膦酸治疗犬的四肢骨肉瘤
J Small Anim Pract. 2009 Jan;50(1):44-6. doi: 10.1111/j.1748-5827.2008.00635.x. Epub 2008 Sep 12.
3
[Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].[一名转移性乳腺癌患者的双膦酸盐诱导的颌骨坏死]
Rev Esp Med Nucl. 2011 Sep-Oct;30(5):322-3. doi: 10.1016/j.remn.2010.12.001. Epub 2011 Mar 26.
4
Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.接受骨靶向治疗患者的颌骨骨坏死：概述——第一部分
Urol Nurs. 2016 May-Jun;36(3):111-6, 154.
5
Downregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine Osteosarcoma.唑来膦酸处理后犬骨肉瘤中CXCR4表达及功能的下调
J Vet Intern Med. 2016 Jul;30(4):1187-96. doi: 10.1111/jvim.14257. Epub 2016 Jun 2.
6
Antiresorptive drug-related osteonecrosis of the jaw.抗吸收药物相关的颌骨坏死
Dent Clin North Am. 2014 Apr;58(2):369-84. doi: 10.1016/j.cden.2013.12.006.
7
Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.考虑原发性疾病和伴随治疗时双膦酸盐相关性颌骨骨坏死的发生率。
Anticancer Res. 2013 Sep;33(9):3917-24.
8
Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.单剂量帕米膦酸盐用于犬肢体骨肉瘤骨痛的姑息治疗
J Vet Intern Med. 2007 May-Jun;21(3):431-9. doi: 10.1892/0891-6640(2007)21[431:spfpto]2.0.co;2.
9
Bisphosphonate-related osteonecrosis of the jaws--a case report.双膦酸盐相关颌骨坏死——一例报告
Compend Contin Educ Dent. 2012 May;33(5):e74-7.
10
Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: similarities with phossy jaw.左半侧下颌骨自发性双膦酸盐相关骨坏死：与磷毒性颌骨坏死的相似之处。
Indian J Dent Res. 2012 Sep-Oct;23(5):683-5. doi: 10.4103/0970-9290.107408.

引用本文的文献

1
An update on oral manifestations of systemic disorders in dogs and cats.犬猫全身性疾病的口腔表现最新进展
Front Vet Sci. 2025 Jan 6;11:1511971. doi: 10.3389/fvets.2024.1511971. eCollection 2024.
2
A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats.一项关于20只猫双膦酸盐相关颌骨坏死的回顾性病例系列研究。
Front Vet Sci. 2024 Aug 23;11:1436988. doi: 10.3389/fvets.2024.1436988. eCollection 2024.
3
An evaluation of the combination effect of zoledronate and chemotherapeutic agents in canine osteosarcoma cells.

本文引用的文献

1
Radiographic Changes and Fracture in Patients Having Received Bisphosphonate Therapy for ≥ 5 Years at a Single Institution.在单一机构接受双膦酸盐治疗≥5年的患者的影像学改变和骨折情况
Mil Med. 2015 Dec;180(12):1214-8. doi: 10.7205/MILMED-D-14-00736.
2
Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma.骨吸收抑制剂在治疗实体瘤或多发性骨髓瘤相关骨转移中的应用。
Bonekey Rep. 2015 Oct 7;4:744. doi: 10.1038/bonekey.2015.113. eCollection 2015.
3
Bisphosphonate-Related Osteonecrosis of the Jaw After Tooth Extraction.
唑来膦酸与化疗药物联合作用于犬骨肉瘤细胞的效果评估。
Front Vet Sci. 2024 Feb 13;11:1327377. doi: 10.3389/fvets.2024.1327377. eCollection 2024.
4
Effects of neoadjuvant zoledronate and radiation therapy on cell survival, cell cycle distribution, and clinical status in canine osteosarcoma.新辅助唑来膦酸与放射治疗对犬骨肉瘤细胞存活、细胞周期分布及临床状态的影响
Front Vet Sci. 2024 Jan 31;11:1237084. doi: 10.3389/fvets.2024.1237084. eCollection 2024.
5
Retrospective assessment of tolerability and efficacy of zoledronate in the palliative treatment of cancer-bearing dogs.回顾性评估唑来膦酸在癌症犬姑息治疗中的耐受性和疗效。
Aust Vet J. 2023 Jan;101(1-2):58-64. doi: 10.1111/avj.13218. Epub 2022 Nov 16.
6
Retrospective Evaluation of Outcome in Dogs With Appendicular Osteosarcoma Following Hypofractionated Palliative Radiation Therapy With or Without Bisphosphonates: 165 Cases (2010-2019).2010 - 2019年165例犬四肢骨肉瘤接受或不接受双膦酸盐的低分割姑息性放射治疗后的疗效回顾性评估
Front Vet Sci. 2022 May 10;9:892297. doi: 10.3389/fvets.2022.892297. eCollection 2022.
7
Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the Literature.白藜芦醇补充对微生物组调节的益处和影响：文献系统评价。
Int J Mol Sci. 2022 Apr 5;23(7):4027. doi: 10.3390/ijms23074027.
8
Toxicity of zoledronic acid after intravenous administration: A retrospective study of 95 dogs.静脉注射唑来膦酸的毒性：95 只狗的回顾性研究。
J Vet Intern Med. 2022 Jan;36(1):253-258. doi: 10.1111/jvim.16335. Epub 2021 Dec 3.
9
Novel applications of platelet concentrates in tissue regeneration (Review).血小板浓缩物在组织再生中的新应用（综述）。
Exp Ther Med. 2021 Mar;21(3):226. doi: 10.3892/etm.2021.9657. Epub 2021 Jan 18.
10
Recent and current clinical trials in canine appendicular osteosarcoma.犬附肢骨肉瘤的近期及当前临床试验。
Can Vet J. 2020 Mar;61(3):301-308.
拔牙后双膦酸盐相关颌骨坏死
J Craniofac Surg. 2015 Oct;26(7):e606-8. doi: 10.1097/SCS.0000000000002051.
4
Bisphosphonate-related osteonecrosis of the jaw in a multiple myeloma patient: A case report with characteristic radiographic features.一名多发性骨髓瘤患者的双膦酸盐相关颌骨坏死：一例具有特征性影像学表现的病例报告
Imaging Sci Dent. 2015 Sep;45(3):199-203. doi: 10.5624/isd.2015.45.3.199. Epub 2015 Sep 9.
5
Zoledronate induces osteonecrosis of the jaw in sheep.唑来膦酸可诱发绵羊颌骨坏死。
J Craniomaxillofac Surg. 2015 Sep;43(7):1133-8. doi: 10.1016/j.jcms.2015.04.020. Epub 2015 Apr 30.
6
Treatment of ionized hypercalcemia in 12 cats (2006-2008) using PO-administered alendronate.2006年至2008年期间，采用口服阿仑膦酸盐对12只猫的离子化高钙血症进行治疗。
J Vet Intern Med. 2015 Jan;29(1):200-6. doi: 10.1111/jvim.12507. Epub 2015 Jan 12.
7
The critical role of bisphosphonates to target bone cancer metastasis: an overview.双膦酸盐在靶向骨癌转移中的关键作用：综述。
J Drug Target. 2015 Jan;23(1):1-15. doi: 10.3109/1061186X.2014.950668. Epub 2014 Sep 9.
8
Malignancy mimicking bisphosphonate-associated osteonecrosis of the jaw: a case series and literature review.模拟双膦酸盐相关性颌骨骨坏死的恶性肿瘤：病例系列及文献复习。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jan;117(1):32-6. doi: 10.1016/j.oooo.2013.08.028.
9
Bisphosphonate related osteonecrosis of the jaw: A minipig large animal model.双膦酸盐相关性颌骨坏死：小型猪大动物模型。
Bone. 2012 Sep;51(3):592-9. doi: 10.1016/j.bone.2012.04.020. Epub 2012 May 7.
10
Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ).双膦酸盐相关颌骨坏死（BRONJ）的诊断指南。
Clin Cases Miner Bone Metab. 2007 Jan;4(1):37-42.